{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:06:18Z","timestamp":1789052778349,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005713","name":"Technische Universit\u00e4t M\u00fcnchen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005713","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"DOI":"10.1007\/s12928-026-01332-9","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:06:20Z","timestamp":1789049180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ten-year outcomes after percutaneous coronary intervention with drug-eluting stents for bifurcation lesions: insights from the DECADE cooperation"],"prefix":"10.1007","author":[{"given":"Constantin","family":"Kuna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J.","family":"Coughlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dik","family":"Heg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorenzo","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"R\u00e4ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Ludwig","family":"Laugwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Windecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Kastrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Cassese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"issue":"Suppl V","key":"1332_CR1","doi-asserted-by":"publisher","first-page":"V23","DOI":"10.4244\/EIJV11SVA5","volume":"11","author":"Y Louvard","year":"2015","unstructured":"Louvard Y, Medina A. Definitions and classifications of bifurcation lesions and treatment. EuroIntervention. 2015;11(Suppl V):V23\u20136.","journal-title":"EuroIntervention"},{"key":"1332_CR2","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jacc.2009.11.049","volume":"55","author":"PW Serruys","year":"2010","unstructured":"Serruys PW, Onuma Y, Garg S, Vranckx P, De Bruyne B, Morice MC, et al. 5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol. 2010;55:1093\u2013101.","journal-title":"J Am Coll Cardiol"},{"key":"1332_CR3","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.4244\/EIJ-D-20-00169","volume":"16","author":"F Burzotta","year":"2021","unstructured":"Burzotta F, Lassen JF, Lefevre T, Banning AP, Chatzizisis YS, Johnson TW, et al. Percutaneous coronary intervention for bifurcation coronary lesions: the 15(th) consensus document from the European Bifurcation Club. EuroIntervention. 2021;16:1307\u201317.","journal-title":"EuroIntervention"},{"key":"1332_CR4","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/j.jcin.2016.06.056","volume":"9","author":"FJ Sawaya","year":"2016","unstructured":"Sawaya FJ, Lefevre T, Chevalier B, Garot P, Hovasse P, Morice MC, et al. Contemporary Approach to Coronary Bifurcation Lesion Treatment. JACC Cardiovasc Interv. 2016;9:1861\u201378.","journal-title":"JACC Cardiovasc Interv"},{"key":"1332_CR5","doi-asserted-by":"publisher","first-page":"e025459","DOI":"10.1161\/JAHA.122.025459","volume":"11","author":"MO Mohamed","year":"2022","unstructured":"Mohamed MO, Lamellas P, Roguin A, Oemrawsingh RM, Ijsselmuiden AJJ, Routledge H, et al. Clinical Outcomes of Percutaneous Coronary Intervention for Bifurcation Lesions According to Medina Classification. J Am Heart Assoc. 2022;11:e025459.","journal-title":"J Am Heart Assoc"},{"key":"1332_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1157\/13084649","volume":"59","author":"A Medina","year":"2006","unstructured":"Medina A, Suarez de Lezo J, Pan M. [A new classification of coronary bifurcation lesions]. Rev Esp Cardiol. 2006;59:183.","journal-title":"Rev Esp Cardiol"},{"key":"1332_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","volume":"40","author":"FJ Neumann","year":"2019","unstructured":"Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC\/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40:87\u2013165.","journal-title":"Eur Heart J"},{"key":"1332_CR8","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"C Vrints","year":"2024","unstructured":"Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes: Developed by the task force for the management of chronic coronary syndromes of the European Society of Cardiology (ESC) Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024;45:3415\u2013537.","journal-title":"Eur Heart J"},{"key":"1332_CR9","doi-asserted-by":"crossref","unstructured":"Banning AP, Lassen JF, Burzotta F, Lefevre T, Darremont O, Hildick-Smith D et al. Percutaneous coronary intervention for obstructive bifurcation lesions: the 14th consensus document from the European Bifurcation Club. EuroIntervention. 2019;15:90\u201398.","DOI":"10.4244\/EIJ-D-19-00144"},{"key":"1332_CR10","doi-asserted-by":"publisher","first-page":"e021632","DOI":"10.1161\/JAHA.121.021632","volume":"10","author":"JM Lee","year":"2021","unstructured":"Lee JM, Lee SH, Kim J, Choi KH, Park TK, Yang JH, et al. Ten-Year Trends in Coronary Bifurcation Percutaneous Coronary Intervention: Prognostic Effects of Patient and Lesion Characteristics, Devices, and Techniques. J Am Heart Assoc. 2021;10:e021632.","journal-title":"J Am Heart Assoc"},{"key":"1332_CR11","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.jcin.2013.08.009","volume":"6","author":"C Girasis","year":"2013","unstructured":"Girasis C, Farooq V, Diletti R, Muramatsu T, Bourantas CV, Onuma Y, et al. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery). JACC Cardiovasc Interv. 2013;6:1250\u201360.","journal-title":"JACC Cardiovasc Interv"},{"key":"1332_CR12","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1080\/14779072.2018.1523717","volume":"16","author":"C Collet","year":"2018","unstructured":"Collet C, Mizukami T, Grundeken MJ. Contemporary techniques in percutaneous coronary intervention for bifurcation lesions. Expert Rev Cardiovasc Ther. 2018;16:725\u201334.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"1332_CR13","doi-asserted-by":"crossref","unstructured":"Coughlan JJ, Maeng M, Raber L, Brugaletta S, Aytekin A, Okkels Jensen L, et al. Ten-year patterns of stent thrombosis after percutaneous coronary intervention with new- versus early-generation drug-eluting stents: insights from the DECADE cooperation. Rev Esp Cardiol (Engl Ed); 2022.","DOI":"10.1016\/j.rec.2022.02.003"},{"key":"1332_CR14","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1093\/eurheartj\/ehp352","volume":"30","author":"RA Byrne","year":"2009","unstructured":"Byrne RA, Kastrati A, Kufner S, Massberg S, Birkmeier KA, Laugwitz KL, et al. Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial. Eur Heart J. 2009;30:2441\u20139.","journal-title":"Eur Heart J"},{"key":"1332_CR15","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.111.026732","volume":"124","author":"S Massberg","year":"2011","unstructured":"Massberg S, Byrne RA, Kastrati A, Schulz S, Pache J, Hausleiter J, et al. Polymer-free sirolimus- and probucol-eluting versus new generation zotarolimus-eluting stents in coronary artery disease: the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting versus Zotarolimus-eluting Stents (ISAR-TEST 5) trial. Circulation. 2011;124:624\u201332.","journal-title":"Circulation"},{"key":"1332_CR16","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/S0140-6736(10)60208-5","volume":"375","author":"K Rasmussen","year":"2010","unstructured":"Rasmussen K, Maeng M, Kaltoft A, Thayssen P, Kelbaek H, Tilsted HH, et al. Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial. Lancet. 2010;375:1090\u20139.","journal-title":"Lancet"},{"key":"1332_CR17","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1056\/NEJMoa051175","volume":"353","author":"S Windecker","year":"2005","unstructured":"Windecker S, Remondino A, Eberli FR, Juni P, Raber L, Wenaweser P, et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med. 2005;353:653\u201362.","journal-title":"N Engl J Med"},{"key":"1332_CR18","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/S0140-6736(12)61223-9","volume":"380","author":"M Sabate","year":"2012","unstructured":"Sabate M, Cequier A, Iniguez A, Serra A, Hernandez-Antolin R, Mainar V, et al. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial. Lancet. 2012;380:1482\u201390.","journal-title":"Lancet"},{"key":"1332_CR19","first-page":"219","volume":"1","author":"G Sianos","year":"2005","unstructured":"Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1:219\u201327.","journal-title":"EuroIntervention"},{"key":"1332_CR20","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","volume":"81","author":"PMTT Grambsch","year":"1994","unstructured":"Grambsch PMTT. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515\u201326.","journal-title":"Biometrika"},{"key":"1332_CR21","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1016\/j.jacc.2015.10.023","volume":"66","author":"SJ Pocock","year":"2015","unstructured":"Pocock SJ, McMurray JJV, Collier TJ. Statistical Controversies in Reporting of Clinical Trials: Part 2 of a 4-Part Series on Statistics for Clinical Trials. J Am Coll Cardiol. 2015;66:2648\u201362.","journal-title":"J Am Coll Cardiol"},{"key":"1332_CR22","first-page":"E248","volume":"87","author":"MJ Grundeken","year":"2016","unstructured":"Grundeken MJ, Wykrzykowska JJ, Ishibashi Y, Garg S, de Vries T, Garcia-Garcia HM, et al. First generation versus second generation drug-eluting stents for the treatment of bifurcations: 5-year follow-up of the LEADERS all-comers randomized trial. Catheter Cardiovasc Interv. 2016;87:E248\u201360.","journal-title":"Catheter Cardiovasc Interv"},{"key":"1332_CR23","doi-asserted-by":"publisher","first-page":"e037657","DOI":"10.1161\/JAHA.124.037657","volume":"14","author":"KH Choi","year":"2025","unstructured":"Choi KH, Nam CW, Bruno F, Cho YK, De Luca L, Kang J, et al. Differential Prognosis of True Bifurcation Lesions According to Left Main Versus Non-Left Main Location and Treatment Strategy. J Am Heart Assoc. 2025;14:e037657.","journal-title":"J Am Heart Assoc"},{"key":"1332_CR24","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.jcin.2024.03.013","volume":"17","author":"LN Andreasen","year":"2024","unstructured":"Andreasen LN, Neghabat O, Laanmets P, Kumsars I, Bennett J, Olsen NT, et al. Unintended Deformation of Stents During Bifurcation PCI: An OCTOBER Trial Substudy. JACC Cardiovasc Interv. 2024;17:1106\u201315.","journal-title":"JACC Cardiovasc Interv"},{"key":"1332_CR25","doi-asserted-by":"publisher","first-page":"e423","DOI":"10.4244\/EIJ-D-23-00063","volume":"19","author":"S Cangemi","year":"2023","unstructured":"Cangemi S, Burzotta F, Bianchini F, DeVos A, Valenzuela T, Trani C, et al. Configuration of two-stent coronary bifurcation techniques in explanted beating hearts: the MOBBEM study. EuroIntervention. 2023;19:e423\u201331.","journal-title":"EuroIntervention"},{"key":"1332_CR26","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.jcin.2022.04.025","volume":"15","author":"K Ninomiya","year":"2022","unstructured":"Ninomiya K, Serruys PW, Garg S, Gao C, Masuda S, Lunardi M, et al. Predicted and Observed Mortality at 10 Years in Patients With Bifurcation Lesions in the SYNTAX Trial. JACC Cardiovasc Interv. 2022;15:1231\u201342.","journal-title":"JACC Cardiovasc Interv"},{"key":"1332_CR27","first-page":"10","volume":"96","author":"R Modolo","year":"2020","unstructured":"Modolo R, Kogame N, Komiyama H, Chichareon P, de Vries T, Tomaniak M, et al. Two years clinical outcomes with the state-of-the-art PCI for the treatment of bifurcation lesions: A sub-analysis of the SYNTAX II study. Catheter Cardiovasc Interv. 2020;96:10\u20137.","journal-title":"Catheter Cardiovasc Interv"},{"key":"1332_CR28","doi-asserted-by":"publisher","first-page":"266","DOI":"10.31083\/j.rcm2409266","volume":"24","author":"Z Mehmedbegovic","year":"2023","unstructured":"Mehmedbegovic Z, Jelic D, Mladenovic D, Stankovic G. DES Selection for Left Main and Coronary Bifurcation Stenting. Rev Cardiovasc Med. 2023;24:266.","journal-title":"Rev Cardiovasc Med"},{"key":"1332_CR29","doi-asserted-by":"publisher","first-page":"e1177","DOI":"10.4244\/EIJ-D-25-00201","volume":"21","author":"S Fezzi","year":"2025","unstructured":"Fezzi S, Scheller B, Rissanen TT, Malivojevic R, Tavella D, Lunardi M, et al. Drug-coated balloons for coronary bifurcation lesions. EuroIntervention. 2025;21:e1177\u201397.","journal-title":"EuroIntervention"},{"key":"1332_CR30","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1093\/eurheartj\/ehaf029","volume":"46","author":"S Fezzi","year":"2025","unstructured":"Fezzi S, Scheller B, Cortese B, Alfonso F, Jeger R, Colombo A, et al. Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research Consortium. Eur Heart J. 2025;46:2498\u2013519.","journal-title":"Eur Heart J"},{"key":"1332_CR31","first-page":"1142","volume":"105","author":"D Strepkos","year":"2025","unstructured":"Strepkos D, Alexandrou M, Mutlu D, Carvalho PEP, Ser OS, Jalli S, et al. Impact of Side Branch Occlusion on Patient Outcomes After Bifurcation Percutaneous Coronary Intervention. Catheter Cardiovasc Interv. 2025;105:1142\u20138.","journal-title":"Catheter Cardiovasc Interv"},{"key":"1332_CR32","doi-asserted-by":"publisher","first-page":"e025394","DOI":"10.1161\/JAHA.122.025394","volume":"11","author":"DY Park","year":"2022","unstructured":"Park DY, An S, Jolly N, Attanasio S, Yadav N, Rao S, et al. Systematic Review and Network Meta-Analysis Comparing Bifurcation Techniques for Percutaneous Coronary Intervention. J Am Heart Assoc. 2022;11:e025394.","journal-title":"J Am Heart Assoc"},{"key":"1332_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jacasi.2021.04.002","volume":"1","author":"CH Lee","year":"2021","unstructured":"Lee CH, Nam CW, Cho YK, Yoon HJ, Kim KB, Gwon HC, et al. 5-Year Outcome of Simple Crossover Stenting in Coronary Bifurcation Lesions Compared With Side Branch Opening. JACC Asia. 2021;1:53\u201364.","journal-title":"JACC Asia"},{"key":"1332_CR34","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.amjcard.2023.09.049","volume":"208","author":"C Servoz","year":"2023","unstructured":"Servoz C, Matta A, Bataille V, Philippe J, Laszlo L, Blanco S, et al. Outcomes of Provisional Stenting With Versus Without Side Branch Intervention in Patients With Bifurcation Lesion-Related ST-Segment Elevation Myocardial Infarction. Am J Cardiol. 2023;208:190\u20134.","journal-title":"Am J Cardiol"},{"key":"1332_CR35","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1007\/s10554-011-9996-x","volume":"28","author":"S Tu","year":"2012","unstructured":"Tu S, Jing J, Holm NR, Onsea K, Zhang T, Adriaenssens T, et al. In vivo assessment of bifurcation optimal viewing angles and bifurcation angles by three-dimensional (3D) quantitative coronary angiography. Int J Cardiovasc Imaging. 2012;28:1617\u201325.","journal-title":"Int J Cardiovasc Imaging"},{"key":"1332_CR36","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1056\/NEJMoa2307770","volume":"389","author":"NR Holm","year":"2023","unstructured":"Holm NR, Andreasen LN, Neghabat O, Laanmets P, Kumsars I, Bennett J, et al. OCT or Angiography Guidance for PCI in Complex Bifurcation Lesions. N Engl J Med. 2023;389:1477\u201387.","journal-title":"N Engl J Med"}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-026-01332-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12928-026-01332-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-026-01332-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:06:22Z","timestamp":1789049182000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12928-026-01332-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":36,"alternative-id":["1332"],"URL":"https:\/\/doi.org\/10.1007\/s12928-026-01332-9","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"value":"1868-4300","type":"print"},{"value":"1868-4297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"20 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not required. The present is a post hoc analysis of 3 randomized trials.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Constantin Kuna received speaker fees from Translumina. Fiorenzo Simonetti is supported by a research grant by the CardioPaTh PhD program. The other authors declare no potential conflict of interest.","order":2,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is one of the largest studies to compare the 10-year outcomes of patients who underwent percutaneous coronary intervention (PCI) with drug-eluting stents for bifurcation and non-bifurcation lesions. The analysis indicates that PCI for bifurcation lesions is more likely to result in cardiovascular death, myocardial infarction, and repeat revascularisation than PCI for non-bifurcation lesions out to the 10-year follow-up. New treatment strategies are needed to improve outcomes for this challenging lesion subset.","order":3,"name":"Ethics","label":"Impact on daily practce","group":{"name":"EthicsHeading","label":"Declarations"}}]}}